{"id":"placebo-intake-once-daily","safety":{"commonSideEffects":[{"rate":null,"effect":"Nocebo effects (adverse events due to negative expectation)"},{"rate":null,"effect":"Delayed treatment of underlying condition if used as sole therapy"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo effects are mediated by psychological expectation, conditioning, and activation of the central nervous system's natural pain-relief and healing pathways, including endogenous opioid and dopamine systems. The effect is not inert but involves measurable physiological changes in brain activity, neurotransmitter release, and immune function. Placebo is often used as a control in clinical trials but can itself produce clinically meaningful improvements in subjective symptoms.","oneSentence":"Placebo produces therapeutic effects through the patient's expectation and belief in treatment, activating endogenous healing mechanisms and neurobiological pathways.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:01:13.153Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in clinical trials"},{"name":"Conditions responsive to expectancy effects (e.g., pain, nausea, fatigue)"}]},"trialDetails":[{"nctId":"NCT03574909","phase":"PHASE3","title":"IRELAnD: Investigating the Role of Early Low-dose Aspirin in Diabetes","status":"COMPLETED","sponsor":"Royal College of Surgeons, Ireland","startDate":"2018-09-01","conditions":"Pre-Gestational Diabetes","enrollment":137},{"nctId":"NCT06896669","phase":"NA","title":"Effects of Vitamin D and Calcium on Hyperglycemia and Dyslipidemia in Patients Gestational Diabetes","status":"COMPLETED","sponsor":"Riphah International University","startDate":"2025-01-28","conditions":"Diabetes Mellitus, Gestational","enrollment":60},{"nctId":"NCT05371496","phase":"PHASE2","title":"Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction","status":"ENROLLING_BY_INVITATION","sponsor":"Mayo Clinic","startDate":"2022-09-06","conditions":"Cardiomyopathy, Heart Failure With Preserved Ejection Fraction (HFpEF), Obesity","enrollment":81},{"nctId":"NCT06841536","phase":"NA","title":"Combined Effects of Statins and Exercise on Training Sensitive Health Markers","status":"COMPLETED","sponsor":"University of the Faroe Islands","startDate":"2025-05-01","conditions":"Dyslipidemias","enrollment":120},{"nctId":"NCT05134441","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Immunic AG","startDate":"2021-11-18","conditions":"Multiple Sclerosis","enrollment":1121},{"nctId":"NCT05201638","phase":"PHASE3","title":"Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Immunic AG","startDate":"2022-01-12","conditions":"Multiple Sclerosis, Relapsing-Remitting","enrollment":1100},{"nctId":"NCT07402278","phase":"NA","title":"Evaluation of HB05P for Muscle Strength Improvement in Older Adults","status":"COMPLETED","sponsor":"Healthbiome Inc","startDate":"2024-09-02","conditions":"Age-Related Muscle Weakness","enrollment":80},{"nctId":"NCT05697640","phase":"PHASE2","title":"Study to Investigate Improvement in Physical Function in SF-36 With Vericiguat Compared With Placebo in Participants With Post-COVID-19 Syndrome","status":"ACTIVE_NOT_RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2023-06-22","conditions":"Post-COVID ME/CFS","enrollment":104},{"nctId":"NCT07362654","phase":"NA","title":"Single-cell Immune Response to Controlled Gluten Ingestion in Pediatric Celiac Disease","status":"RECRUITING","sponsor":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","startDate":"2025-07-07","conditions":"Celiac Disease, Gluten Sensitivity, Autoimmune Diseases","enrollment":45},{"nctId":"NCT06970964","phase":"NA","title":"Fermented Milk Drink With Lacticaseibacillus Paracasei Strain Shirota Helps Triathletes With Cold-Like Symptoms Before and After a Race","status":"COMPLETED","sponsor":"Federal University of São Paulo","startDate":"2025-08-13","conditions":"Respiratory Tract Infections (RTI), Mucosal Immunity, Systemic Inflammation","enrollment":80},{"nctId":"NCT07062159","phase":"NA","title":"Psychoeducational Intervention to Reduce Depressive Symptoms and Strengthen Mother-Infant Bonding","status":"COMPLETED","sponsor":"Yasemin Ozhuner","startDate":"2025-07-02","conditions":"Postpartum Depression, Psychoeducation, Mother-Infant Interaction","enrollment":88},{"nctId":"NCT07324408","phase":"PHASE1","title":"Multiple Ascending Dose Study of NH102 in Healthy Subjects","status":"COMPLETED","sponsor":"Jiangsu Nhwa Pharmaceutical Co., Ltd.","startDate":"2022-03-10","conditions":"Depression","enrollment":40},{"nctId":"NCT05999435","phase":"PHASE2, PHASE3","title":"Study of LAU-7b for the Treatment of Long COVID in Adults","status":"COMPLETED","sponsor":"Laurent Pharmaceuticals Inc.","startDate":"2023-11-15","conditions":"Long COVID","enrollment":272},{"nctId":"NCT05209984","phase":"PHASE3","title":"A Phase 3, Double-blind/Double-dummy, Safety/Efficacy/Superiority of Sibutramine/Topiramate XR in Adults With Overweight","status":"WITHDRAWN","sponsor":"Eurofarma Laboratorios S.A.","startDate":"2026-04","conditions":"Overweight, Obesity","enrollment":""},{"nctId":"NCT07073781","phase":"NA","title":"Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regulation","status":"RECRUITING","sponsor":"Leeds Beckett University","startDate":"2025-08-15","conditions":"Impaired Glucose Regulation, Impaired Glucose Tolerance (Prediabetes), Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)","enrollment":70},{"nctId":"NCT07225413","phase":"NA","title":"Short-Term Rhodiola Rosea for Anaerobic Performance and Cognitive Function in Resistance-Trained Adults","status":"COMPLETED","sponsor":"Jacksonville State University","startDate":"2022-02-01","conditions":"Healthy Volunteers","enrollment":27},{"nctId":"NCT06522997","phase":"PHASE2","title":"A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bayer","startDate":"2024-08-08","conditions":"Chronic Kidney Disease","enrollment":700},{"nctId":"NCT02472795","phase":"PHASE1, PHASE2","title":"Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus","status":"COMPLETED","sponsor":"Viatris Innovation GmbH","startDate":"2015-06-01","conditions":"Systemic Lupus Erythematosus","enrollment":105},{"nctId":"NCT06650644","phase":"NA","title":"A Study to Evaluate the Efficacy and Safety of Lactococcus Lactis KD10 Powder for Improving Autism Spectrum Symptoms in Children With Autism Spectrum Symptoms.","status":"COMPLETED","sponsor":"Miae Oh","startDate":"2024-10-10","conditions":"Autism Spectrum Disorder","enrollment":48},{"nctId":"NCT07116811","phase":"PHASE3","title":"Steroids for Facial Nerve Function Protection in Post-surgical Vestibular Schwannoma Patients","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-01","conditions":"Vestibular Schwannoma, Facial Nerve Paralysis","enrollment":364},{"nctId":"NCT07098624","phase":"NA","title":"Clinical Study to Assess the Safety and Efficacy of ACV Moringa Effervescent Tablet Intake on Weight Management in Overweight and Class I Obese Study Participants","status":"NOT_YET_RECRUITING","sponsor":"NovoBliss Research Pvt Ltd","startDate":"2025-07-24","conditions":"Obese or Overweight Healthy Volunteers","enrollment":66},{"nctId":"NCT07099612","phase":"NA","title":"Smart Blister Packaging and Mobile Application to Monitor and Support Medication Adherence: a Two-arm Usability Study","status":"COMPLETED","sponsor":"University Medical Center Groningen","startDate":"2024-02-05","conditions":"Healthy Volunteer Study","enrollment":36},{"nctId":"NCT03994172","phase":"PHASE4","title":"Novel Combination Therapy for Osteoporosis in Men","status":"ACTIVE_NOT_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2019-07-01","conditions":"Male Osteoporosis","enrollment":40},{"nctId":"NCT06809166","phase":"PHASE4","title":"Metabolic and Behavioural Effects of CONTRAVE as Potential Mechanisms of Weight Loss in Adults With Obesity","status":"RECRUITING","sponsor":"The Royal's Institute of Mental Health Research","startDate":"2024-07-04","conditions":"Obesity, Weight Loss, Weight Management","enrollment":40},{"nctId":"NCT07048860","phase":"NA","title":"ICOPE INTENSE-K Pilot Study","status":"RECRUITING","sponsor":"University Hospital, Toulouse","startDate":"2025-07-09","conditions":"Ageing","enrollment":40},{"nctId":"NCT06955819","phase":"NA","title":"GUTPROH: Probiotic-Herbal Formula for Self-Reported Constipation in Community Adults","status":"NOT_YET_RECRUITING","sponsor":"Beijing Hospital","startDate":"2025-07-10","conditions":"Functional Constipation (FC)","enrollment":300},{"nctId":"NCT07033637","phase":"NA","title":"Probiotics and Active Aging: Enhancing Gut Health","status":"NOT_YET_RECRUITING","sponsor":"Jose Luis Felipe","startDate":"2025-09-01","conditions":"Gut -Microbiota, Older People, Physical Activity","enrollment":90},{"nctId":"NCT05890664","phase":"PHASE3","title":"Colchicine After Electrocardioversion for Atrial Fibrillation","status":"RECRUITING","sponsor":"University Hospital, Basel, Switzerland","startDate":"2024-04-14","conditions":"Atrial Fibrillation, Cardiac Arrhythmia","enrollment":416},{"nctId":"NCT06987097","phase":"NA","title":"Ambrisentan for Early Low-Risk Pulmonary Arterial Hypertension","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2025-05-15","conditions":"Pulmonary Arterial Hypertension (PAH)","enrollment":410},{"nctId":"NCT03968003","phase":"NA","title":"Impact of Dietary Fiber as Prebiotics on Intestinal Microbiota in Obese Thai Children","status":"COMPLETED","sponsor":"Chulalongkorn University","startDate":"2017-08-01","conditions":"Obesity","enrollment":165},{"nctId":"NCT06183242","phase":"PHASE2, PHASE3","title":"Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-05-27","conditions":"Cholestasis, Intrahepatic","enrollment":328},{"nctId":"NCT06573814","phase":"PHASE2","title":"The Effects of Bio Gelee Royale Forte on Immune Health in Healthy Adults","status":"COMPLETED","sponsor":"Medex d.o.o.","startDate":"2024-10-25","conditions":"Upper Respiratory Tract Infection, URTI","enrollment":100},{"nctId":"NCT03649997","phase":"PHASE1","title":"A Study of Single and Multiple Ascending Doses of JNJ-61393215 in Healthy Participants","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2018-08-28","conditions":"Healthy","enrollment":57},{"nctId":"NCT04855201","phase":"PHASE1","title":"A Study to Evaluate ASP0367 in Participants With Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction","status":"TERMINATED","sponsor":"Astellas Pharma Global Development, Inc.","startDate":"2021-06-14","conditions":"Reduced Maximum Oxygen Uptake Due to Poor Systemic Oxygen Extraction","enrollment":31},{"nctId":"NCT06281106","phase":"PHASE2, PHASE3","title":"TYK2 Inhibition in Paradoxical Psoriasis","status":"TERMINATED","sponsor":"Prof Curdin Conrad","startDate":"2024-06-20","conditions":"Psoriasis","enrollment":2},{"nctId":"NCT04008355","phase":"PHASE2","title":"A Study to Assess Tolerability, Safety, Pharmacokinetics and Effect of AZP2006 in Patients With PSP","status":"COMPLETED","sponsor":"AlzProtect SAS","startDate":"2020-06-22","conditions":"Progressive Supranuclear Palsy","enrollment":36},{"nctId":"NCT05384431","phase":"PHASE3","title":"Can We Achieve 'high-quality' Weight Loss Through Supplementation and Exercise? the TRIM MUSCLE Study","status":"COMPLETED","sponsor":"Exerkine Corporation","startDate":"2022-08-15","conditions":"Overweight, Obesity","enrollment":51},{"nctId":"NCT06760468","phase":"NA","title":"Development and Evaluation of Functional Probiotic Powder in Human Trials","status":"NOT_YET_RECRUITING","sponsor":"Chengdu Sport University","startDate":"2025-02-01","conditions":"Exercise Fatigue","enrollment":60},{"nctId":"NCT03279978","phase":"PHASE1","title":"This Study Tests How Healthy Men Tolerate Different Doses of BI 730357 and How the Metabolism of Midazolam is Affected by BI 730357","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2018-01-09","conditions":"Healthy, Psoriasis","enrollment":83},{"nctId":"NCT04482478","phase":"NA","title":"Clinical Trial for the Evaluation of the Efficacy and Safety of EDL on Dyspepsia","status":"RECRUITING","sponsor":"Seoul National University Bundang Hospital","startDate":"2020-07-01","conditions":"Functional Dyspepsia","enrollment":100},{"nctId":"NCT04545151","phase":"PHASE2","title":"Verapamil SR in Adults With Type 1 Diabetes","status":"ACTIVE_NOT_RECRUITING","sponsor":"Medical University of Graz","startDate":"2021-02-08","conditions":"Diabetes Mellitus, Type 1","enrollment":138},{"nctId":"NCT05236517","phase":"PHASE1","title":"A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2022-02-08","conditions":"Obesity","enrollment":60},{"nctId":"NCT05864716","phase":"NA","title":"Colonoscopic Probiotics Spray in Irritable Bowel Syndrome","status":"NOT_YET_RECRUITING","sponsor":"National Cheng-Kung University Hospital","startDate":"2024-10-01","conditions":"Effect of Drug","enrollment":66},{"nctId":"NCT03649698","phase":"NA","title":"Exercise and Nutrition for Healthy AgeiNg","status":"RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2018-02-12","conditions":"Sarcopenia","enrollment":180},{"nctId":"NCT00699413","phase":"PHASE4","title":"Supplements for Controlling Resistance to Insulin","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2008-02","conditions":"Obesity, Diabetes Mellitus, Type 2","enrollment":8},{"nctId":"NCT00529373","phase":"PHASE3","title":"A Study of MK-0822 in Postmenopausal Women With Osteoporosis to Assess Fracture Risk (MK-0822-018)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2007-09-13","conditions":"Postmenopausal Osteoporosis","enrollment":16071},{"nctId":"NCT04311411","phase":"PHASE1","title":"A Study of Tirzepatide in Overweight and Very Overweight Participants","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2020-08-24","conditions":"Obesity, Overweight","enrollment":114},{"nctId":"NCT04803396","phase":"PHASE1","title":"Ascending Dose Tolerability Trial and PK Assessment in Healthy Volunteers After Single & Multiple Oral Intake of DF2755A","status":"TERMINATED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2018-11-15","conditions":"no Condition","enrollment":32},{"nctId":"NCT06332248","phase":"NA","title":"Possible Effects of the Dietary Supplement Magnesium Compared to Placebo","status":"COMPLETED","sponsor":"Dan Hasson","startDate":"2014-09-15","conditions":"Health Promotion","enrollment":1013},{"nctId":"NCT06095765","phase":"PHASE3","title":"Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention","status":"RECRUITING","sponsor":"AZ Sint-Jan AV","startDate":"2024-01-29","conditions":"Coronary Artery Disease","enrollment":2770},{"nctId":"NCT01722266","phase":"PHASE3","title":"Liraglutide in the Treatment of Type 1 Diabetes Mellitus","status":"COMPLETED","sponsor":"University at Buffalo","startDate":"2012-11-01","conditions":"Type 1 Diabetes","enrollment":72},{"nctId":"NCT06017284","phase":"PHASE3","title":"Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer","status":"RECRUITING","sponsor":"Fudan University","startDate":"2023-11-01","conditions":"Pancreatic Cancer Stage IV, Chemotherapy-induced Nausea and Vomiting","enrollment":100},{"nctId":"NCT03824041","phase":"NA","title":"Effects of Aronia Berries on Vascular Endothelial Function and the Gut Microbiota in Middle-Aged/Older Adults","status":"COMPLETED","sponsor":"Colorado State University","startDate":"2019-02-11","conditions":"Endothelial Dysfunction, Aging","enrollment":24},{"nctId":"NCT05845983","phase":"NA","title":"LA Improves the Prognosis of Patients With ICVD","status":"NOT_YET_RECRUITING","sponsor":"Huaqiu Zhang","startDate":"2023-05-04","conditions":"Ischemia, Cerebrovascular Ischemia, Cognitive Impairment","enrollment":236},{"nctId":"NCT05727579","phase":"PHASE4","title":"DiEtary Sodium Intake Effects on Ertugliflozin-induced Changes in GFR, reNal Oxygenation and Systemic Hemodynamics: the DESIGN Study","status":"NOT_YET_RECRUITING","sponsor":"Amsterdam UMC, location VUmc","startDate":"2023-06-01","conditions":"Diabetes Mellitus, Diabetic Kidney Disease, Hypertension","enrollment":34},{"nctId":"NCT02617017","phase":"PHASE3","title":"Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-06-17","conditions":"Parkinson","enrollment":99},{"nctId":"NCT05806476","phase":"NA","title":"Caffeine, DNA and Cognition","status":"UNKNOWN","sponsor":"St. Mary's University, Twickenham","startDate":"2023-02-22","conditions":"Cognitive Function 1, Social","enrollment":42},{"nctId":"NCT01478477","phase":"NA","title":"Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole","status":"COMPLETED","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2011-10-04","conditions":"Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer","enrollment":44},{"nctId":"NCT04649203","phase":"PHASE3","title":"Cytoflavin in the Treatment of Patients With Diabetic Polyneuropathy","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2020-11-25","conditions":"Diabetic Neuropathies","enrollment":216},{"nctId":"NCT04886297","phase":"PHASE3","title":"A Dose-response Study of Dietary Resveratrol on Lipid Metabolism Disorder","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2021-05-01","conditions":"Dyslipidemias","enrollment":168},{"nctId":"NCT04972656","phase":"NA","title":"Treatment With Ambrisentan in Patients With Borderline Pulmonary Arterial Hypertension","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2022-09-05","conditions":"Pulmonary Arterial Hypertension","enrollment":420},{"nctId":"NCT04776044","phase":"PHASE2","title":"Clinical Trial to Evaluate the Safety and Efficacy of ATR-002 in Adult Hospitalized Patients With COVID-19","status":"TERMINATED","sponsor":"Atriva Therapeutics GmbH","startDate":"2021-04-12","conditions":"COVID-19","enrollment":133},{"nctId":"NCT04891302","phase":"PHASE2","title":"The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19","status":"COMPLETED","sponsor":"Bukwang Pharmaceutical","startDate":"2021-03-19","conditions":"COVID-19","enrollment":104},{"nctId":"NCT04347915","phase":"PHASE2","title":"The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19","status":"COMPLETED","sponsor":"Bukwang Pharmaceutical","startDate":"2020-05-26","conditions":"COVID-19","enrollment":64},{"nctId":"NCT04132791","phase":"NA","title":"TIME ASPIRIN: Chronotherapy With Aspirin for Reduction of Cardiovascular Disease","status":"TERMINATED","sponsor":"Leiden University Medical Center","startDate":"2019-10-07","conditions":"Cardiovascular Diseases","enrollment":328},{"nctId":"NCT02607449","phase":"PHASE3","title":"FS-1 Drug for Treatment of Multiple Drug-resistant Tuberculosis","status":"COMPLETED","sponsor":"Scientific Center for Anti-infectious Drugs, Kazakhstan","startDate":"2013-12","conditions":"Tuberculosis, MDR","enrollment":344},{"nctId":"NCT05387876","phase":"NA","title":"Vitamin D Intervention and Associated Changes in the Gut Microbiome and Vitamin D Levels in Healthy Adults","status":"UNKNOWN","sponsor":"Baylor University","startDate":"2022-02-14","conditions":"Colorectal Cancer","enrollment":43},{"nctId":"NCT03573336","phase":"PHASE2","title":"Assess Safety and Efficacy of Vilaprisan in Subjects With Endometriosis","status":"TERMINATED","sponsor":"Bayer","startDate":"2018-07-04","conditions":"Endometriosis","enrollment":8},{"nctId":"NCT03702374","phase":"PHASE3","title":"Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy","status":"COMPLETED","sponsor":"University of Guadalajara","startDate":"2018-09-26","conditions":"Diabetic Retinopathy","enrollment":132},{"nctId":"NCT03201419","phase":"PHASE2","title":"A Trial to Investigate Efficacy, Safety and Tolerability of FE 201836 for Nocturia Due to Nocturnal Polyuria in Adults","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2017-07-27","conditions":"Nocturia","enrollment":302},{"nctId":"NCT00779532","phase":"PHASE1","title":"Thorough QT/QTc Study of Multiple Oral Doses of NOMAC-E2 (Org 10486 0 + Org 2317) in Healthy Women (Study 292011)(P05802)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05","conditions":"Contraception","enrollment":189},{"nctId":"NCT01742702","phase":"","title":"HaemoDYNAMICs in Primary and Secondary Hypertension","status":"UNKNOWN","sponsor":"Tampere University","startDate":"2006-05-25","conditions":"Primary Hypertension, Secondary Hypertension, Aortic Stenosis","enrollment":2000},{"nctId":"NCT01665378","phase":"NA","title":"Impact of Pre-pregnancy Micronutrient Supplementation on Maternal and Child Outcomes","status":"COMPLETED","sponsor":"Emory University","startDate":"2011-10","conditions":"Anemia, Intrauterine Growth Retardation, Preterm Delivery","enrollment":5011},{"nctId":"NCT03361098","phase":"PHASE4","title":"DECREASE: Dapagliflozin Plus Exenatide on Central REgulation of Appetite in diabeteS typE 2","status":"COMPLETED","sponsor":"Amsterdam UMC, location VUmc","startDate":"2017-09-18","conditions":"Type 2 Diabetes Mellitus, Obesity","enrollment":65},{"nctId":"NCT04229407","phase":"NA","title":"Evaluate the Effect of Dietary Supplement on Muscle Mass and Physical Performance for Over 50 Years Old People","status":"COMPLETED","sponsor":"Orient Europharma Co., Ltd.","startDate":"2018-03-12","conditions":"Muscle Loss","enrollment":80},{"nctId":"NCT02773381","phase":"PHASE1","title":"A Trial Investigating the Effect of Oral Semaglutide Compared With Placebo on Postprandial Glucose and Triglyceride Metabolism, Energy Intake, Appetite Sensations and Gastric Emptying in Subjects With Type 2 Diabetes","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"2016-06-02","conditions":"Diabetes, Diabetes Mellitus, Type 2","enrollment":15},{"nctId":"NCT03341429","phase":"PHASE4","title":"Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response","status":"COMPLETED","sponsor":"University College, London","startDate":"2018-08-22","conditions":"Obesity","enrollment":70},{"nctId":"NCT03110458","phase":"PHASE2","title":"Efficacy of SENS-111 in Patients Suffering From Acute Unilateral Vestibulopathy","status":"COMPLETED","sponsor":"Sensorion","startDate":"2017-08-16","conditions":"Acute Unilateral Vestibulopathy (AUV)","enrollment":107},{"nctId":"NCT04428593","phase":"PHASE1","title":"Study to Assess Safety, Tolerability and Pharmacokinetics of Treamid in Healthy Volunteers","status":"COMPLETED","sponsor":"PHARMENTERPRISES LLC","startDate":"2016-01-25","conditions":"Metabolic Syndrome","enrollment":20},{"nctId":"NCT03301155","phase":"PHASE4","title":"Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI","status":"COMPLETED","sponsor":"Materia Medica Holding","startDate":"2017-10-03","conditions":"Preventive Medicine","enrollment":1036},{"nctId":"NCT03628937","phase":"NA","title":"The Effect of Decaffeinated Green Tea Polyphenol Intake on the Risk of Precocious Puberty Among Obese Girls","status":"UNKNOWN","sponsor":"Xinhua Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2018-08-28","conditions":"Pediatric Obesity, Puberty, Precocious","enrollment":80},{"nctId":"NCT03418376","phase":"NA","title":"Carnosine Loading and Periodized Training in MS and HC","status":"COMPLETED","sponsor":"Hasselt University","startDate":"2017-02-01","conditions":"Multiple Sclerosis, Exercise Therapy, Dietary Supplement","enrollment":45},{"nctId":"NCT04325581","phase":"PHASE3","title":"Laparocopic Sleeve Gastrectomy With or Without Liraglutide in Obese Patients","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2016-08-01","conditions":"Weight Loss","enrollment":16},{"nctId":"NCT04135885","phase":"NA","title":"Folic Acid Intervention During Recovery","status":"UNKNOWN","sponsor":"Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University","startDate":"2019-12-30","conditions":"Adverse Effect of Other General Anesthetics","enrollment":300},{"nctId":"NCT02358265","phase":"PHASE3","title":"Chronic Urticaria - Long Term Assessment of Effects of Rupatadine","status":"TERMINATED","sponsor":"Charite University, Berlin, Germany","startDate":"2014-12","conditions":"Chronic Urticaria","enrollment":192},{"nctId":"NCT03854942","phase":"PHASE1","title":"Study of the Opioid Modulation of the Effect of Alcohol on the Dopaminergic Reward System","status":"TERMINATED","sponsor":"RWTH Aachen University","startDate":"2011-08-30","conditions":"Alcohol Addiction","enrollment":43},{"nctId":"NCT01803607","phase":"PHASE3","title":"Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)","status":"TERMINATED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2013-03-14","conditions":"Osteoporosis","enrollment":135},{"nctId":"NCT02839421","phase":"PHASE4","title":"Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis Treatment","status":"UNKNOWN","sponsor":"Facultad Nacional de Salud Publica","startDate":"2015-12","conditions":"Aggressive Periodontitis","enrollment":36},{"nctId":"NCT01871649","phase":"PHASE3","title":"Initial Treatment With Golimumab in Early PsA","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2013-08","conditions":"Psoriatic Arthritis","enrollment":51},{"nctId":"NCT02119260","phase":"PHASE2","title":"A First Time in Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Healthy Subjects and Stable Heart Failure Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2014-06-09","conditions":"Oedema, Pulmonary","enrollment":61},{"nctId":"NCT03134469","phase":"NA","title":"Efficacy of Probiotics on Excessive Gas Accumulation","status":"COMPLETED","sponsor":"Probi AB","startDate":"2017-04-18","conditions":"Flatulence, Bloating","enrollment":64},{"nctId":"NCT01120600","phase":"PHASE3","title":"A Study to Assess Safety and Efficacy of Odanacatib (MK-0822) in Men With Osteoporosis (MK-0822-053)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-06-09","conditions":"Osteoporosis","enrollment":294},{"nctId":"NCT00885170","phase":"PHASE2","title":"A Study to Evaluate the Safety, Tolerability, and Efficacy of Odanacatib (MK-0822) in Postmenopausal Women Previously Treated With a Bisphosphonate (MK-0822-042)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2009-04-13","conditions":"Osteoporosis","enrollment":246},{"nctId":"NCT00729183","phase":"PHASE3","title":"Study to Evaluate Efficacy of Odanacatib (MK-0822) on Bone Mineral Density (BMD) and Bone Micro-architecture and Overall Safety in Postmenopausal Women (MK-0822-031)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-10-02","conditions":"Osteoporosis","enrollment":214},{"nctId":"NCT03078179","phase":"NA","title":"Effect of Lactobacillus Rhamnosus GG and Bifidobacterium Longum in Children Aged 3 to 5 Years of Villavicencio and Pasto","status":"COMPLETED","sponsor":"Cooperative University of Colombia","startDate":"2017-06-05","conditions":"Caries, Dental","enrollment":100},{"nctId":"NCT01601847","phase":"PHASE4","title":"Wheezing in Black Preterm Infants: Impact of Vitamin D Supplementation Strategy","status":"COMPLETED","sponsor":"Case Western Reserve University","startDate":"2013-01","conditions":"Wheezing, Allergy","enrollment":300},{"nctId":"NCT00748605","phase":"PHASE2","title":"Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie Diet","status":"COMPLETED","sponsor":"Shionogi","startDate":"2007-06","conditions":"Obesity","enrollment":842},{"nctId":"NCT03459391","phase":"PHASE1","title":"Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers","status":"COMPLETED","sponsor":"PHARMENTERPRISES LLC","startDate":"2017-05-22","conditions":"Influenza, Acute Respiratory Infection","enrollment":32},{"nctId":"NCT00112437","phase":"PHASE2","title":"A Study to Examine the Effects of an Experimental Drug on Postmenopausal Osteoporosis (MK-0822-004)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2005-06-24","conditions":"Osteoporosis","enrollment":399},{"nctId":"NCT02692742","phase":"PHASE2","title":"Efficacy and Safety Phase IIa Study of Myelo001 in Chemotherapy-Induced Neutropenia","status":"COMPLETED","sponsor":"Myelo Therapeutics GmbH","startDate":"2016-03","conditions":"Chemotherapy-Induced Neutropenia, Myelosuppression, Breast Cancer","enrollment":137}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":265,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Placebo intake once daily","genericName":"Placebo intake once daily","companyName":"Medical University of Vienna","companyId":"medical-university-of-vienna","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Placebo produces therapeutic effects through the patient's expectation and belief in treatment, activating endogenous healing mechanisms and neurobiological pathways. Used for Control arm in clinical trials, Conditions responsive to expectancy effects (e.g., pain, nausea, fatigue).","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}